198
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Bilateral femoral head dysplasia and osteochondritis

Multiple epiphyseal dysplasia tarda, spondylo-epiphyseal dysplasisa tarda, and bilateral Legg-Perthes disease

, , &
Pages 705-709 | Accepted 03 May 1988, Published online: 04 Jan 2010
 

Abstract

Multiple epiphyseal dysplasia tarda (MEDT) and spondylo-epiphyseal dysplasisa tarda (SEDT) are genetically transmitted conditions affecting the hips, which may resemble bilateral Legg-Perthes disease (LPD). Misdiagnoses are not uncommon, with serious implications for treatment, prognosis and genetic counseling. an epidemiologic study of MEDT and SEDT in a well-defined population of 453921 persons in Denmark was performed. A population prevalence of 0.7 per 100000 inhabitants with SEDT and 4.0 per 100000 inhabitants with MEDT was found. Distinguishing features between MEDT, SEDT and bilateral LPD based on radiologic findings in the hips, other joints, and spine were ascertained. Bilateral LPD is always asymmetric, exhibits patches of increased density in the epiphyses and often metaphyseal cyst-like changes. No spinal lesion or affection of other joints is present, and the acetabula are normal. in MEDT and SEDT the capital femoral epiphyses are symmetrically flattened, fragmented and uniformly slightly sclerotic. Generalised platyspondyly is a constant finding in SEDT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.